LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

30 Million Children Vaccinated by Global Agencies

By Biotechdaily staff writers
Posted on 30 Jul 2003
Five-year commitments to immunize children in the world's poorest countries have exceeded US$1 billion, according to the Global Alliance for Vaccines and Immunization (GAVI, Washington, DC, USA). Already, 30 million children have benefited from the nearly $250 million in new vaccines and infrastructure disbursed so far.

Including Angola, Chad, and Congo, which were recently approved for funding, 71 countries have received vaccines from The Vaccine Fund, the financing arm of GAVI. Many of these are showing impressive signs of success. Immunization rates in Mali and Uganda, for example, have reversed their falling coverage rate of the late 1990s and are now reaching even more children than they had anticipated in their original application. The agencies estimate that global immunization efforts will prevent as many as 300,000 deaths. Two out of every three nonimmunized children are in five countries: India, Nigeria, China, Pakistan, and Indonesia.

GAVI was created as a public/private partnership to reverse the decline in immunization coverage in developing countries during the 1990s and was launched with an initial grant from the Bill & Melinda Gates Foundation. Other participants include national governments, UNICEF, WHO, The World Bank, the vaccine industry, and public health organizations.

"As new vaccines become available and more children are born in developing countries, costs are soaring for The Vaccine Fund,” said Jacques-Francois Martin, president. "We urgently need to raise more money and bring new public and private donors to the table.”




Related Links:
Global Alliance for Vaccines and Immunization

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Prefilled Tubes
Prefilled 5.0ml Tubes
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test

Latest BioResearch News

D-Serine May Predict Immune Checkpoint Therapy Resistance in Gastric Cancer
30 Jul 2003  |   BioResearch

New Genetic Cause Identified for Neurodevelopmental Disorder
30 Jul 2003  |   BioResearch

New Genetic Discovery Could Support Precision Diabetes Care
30 Jul 2003  |   BioResearch